Niopeg (pegfilgrastim biosimilar) / Sunshine Biopharma - LARVOL DELTA

Sunshine Biopharma Launches NIOPEG(R) Into $10 Billion Biologics Market (Yahoo Finance) - "Sunshine Biopharma Inc...announced that its wholly owned Canadian subsidiary, Nora Pharma Inc., has launched NIOPEG, the Company's first Biosimilar drug on the market...It is indicated to decrease the incidence of infection in patients with non-myeloid malignancies receiving chemotherapy. NIOPEGis available in a prefilled syringe of 6mg/0.6mL."

Biosimilar launch • Oncology